what is equity funding: 2026 Guide | CT Acquisitions
Lower-middle-market operator reviewing an equity funding term sheet with a capital advisor
What is equity funding, in plain English, for an operator running a real business between $1M and $25M of EBITDA.

Updated Q3 2026 by CT Acquisitions.

What is equity funding? A 2026 guide for lower-middle-market operators

What is equity funding? It is capital exchanged for an ownership stake in your company instead of a repayment obligation. For a lower-middle-market operator running a business with $3M to $50M in revenue and $1M to $25M of EBITDA, equity funding is how you finance a growth push, a partial owner liquidity event, an add-on acquisition roll-up, or a full recapitalization without loading the balance sheet with senior debt at the 2024-2026 rate environment where SOFR plus 550 to 750 basis points is common for unitranche facilities, according to S&P Global Market Intelligence.

This guide is written for the operator who is not a Silicon Valley pre-seed founder and is not raising a Series A on a napkin. You already have customers, cash flow, and a team. You are asking whether to sell 20% to a family office, 51% to a growth equity fund, or 100% with a rollover to a private equity platform. We wrote this because the top of the SERP for “what is equity funding” is dominated by generic VC-first content that assumes you are pitching Sequoia. That is not you.

Key Takeaways

  • Equity funding trades ownership for capital with no fixed repayment, unlike senior debt or mezzanine, and is priced on a multiple of EBITDA or revenue.
  • Lower-middle-market equity checks in 2025 ranged from $5M to $150M, with growth minority deals typically clearing at 8.0x to 11.5x EBITDA per GF Data.
  • Family offices deployed a record $124T in global assets in 2024 per Cerulli, and now compete directly with private equity for control deals.
  • Recapitalizations let owners take chips off the table (typically 20% to 80% liquidity) while keeping operational control and a second bite of the apple.
  • Growth equity and control PE both exist in the LMM but differ on governance, leverage, and time horizon; the fit depends on your growth thesis and role preference.
  • Total transaction cost for an LMM equity raise runs 3% to 8% of proceeds, including advisor success fee, legal, quality of earnings, and closing costs.
  • PE dry powder hit $2.62T globally by mid-2025 per Bain, but the LMM segment saw a 22% drop in deal count during 2023-2024, so pricing has bifurcated by quality tier.
  • The right equity partner is a matching problem, not a maximum-price problem; wrong-fit capital can destroy value even at a premium multiple.
  • CT Acquisitions runs a curated sell-side and capital raise process against 400+ vetted PE, family office, and growth equity sponsors focused on the LMM.

What exactly is equity funding, in plain English?

Equity funding is the sale of an ownership stake in your business in exchange for cash, with no fixed obligation to repay. Unlike a bank loan, the investor participates in future upside and shares in downside risk. In the LMM, equity is typically priced as a multiple of trailing 12-month EBITDA, ranging from 6.0x to 12.0x depending on quality, size, and sector, according to GF Data’s 2025 valuation report.

Think of equity funding as bringing on a co-owner rather than borrowing money. The check they write is not a loan. There is no principal to pay back, no maturity date, no coupon. In exchange, they own a piece of everything the business is worth today and everything it will be worth on exit. That is the trade. You give up permanent economic participation on a piece of the pie in exchange for a lump of capital today.

The right question is not “should I take equity funding” as an abstract preference. The right question is “which structure and which partner fits my growth thesis, my role preference, and my time horizon.” An operator who wants to double the business over five years and then sell will make different equity funding choices than an operator who wants to take chips off the table today and coast for another decade. Both are legitimate.

In our lane, the LMM, equity funding rarely looks like the movie version of a founder in a hoodie signing a term sheet with Andreessen Horowitz. It looks like a 58-year-old owner of a $12M EBITDA specialty distributor sitting across from a family office principal or a middle-market PE partner, working out whether to sell 45% for $54M or 80% for $96M. The mechanics are the same as venture capital in only the loosest possible sense.

Who typically uses equity funding in the lower middle market?

LMM equity funding is used by owner-operators between $3M and $50M in revenue with $1M to $25M of EBITDA, typically to fund growth, take partial liquidity, finance an acquisition roll-up, or transition ownership. Common users include founder-owned businesses, second-generation family businesses, and physician-owned platforms in verticals such as HVAC, dental, IT services, industrial services, and specialty distribution. Sponsors including Audax Group and The Riverside Company have been particularly active in the sub-$50M EBITDA segment through 2024 and 2025.

The three most common LMM equity funding profiles we see at CT Acquisitions are the founder in their late 50s or early 60s who wants a partial liquidity event before a full sale in five years, the second-generation family owner who bought out siblings and now needs growth capital to expand, and the operating executive who has done one leveraged buyout with a sponsor and is now looking to do another one.

You are probably not a good candidate for equity funding if your business generates less than $1M of EBITDA, if you have no clear use of proceeds beyond “growth,” or if you are unwilling to accept board oversight or reporting cadence. Sub-$1M EBITDA businesses generally get better outcomes from an SBA-backed acquisition loan or asset-based lending than from a diluted equity raise, and we have published a dedicated primer on business acquisition loan structures for that segment.

You are probably a strong candidate if your business has three to five years of audited or reviewed financials, gross margin above the sector norm, a defensible market position, and a specific plan for the capital. Sponsors underwrite the plan, not the intention.

How does equity funding compare to debt, mezzanine, and other capital sources?

Equity funding is the most expensive form of capital on paper but the most patient and the most aligned with growth outcomes. Senior debt at SOFR plus 300 to 500 basis points is cheapest but requires collateral and repayment. Mezzanine debt at 11% to 14% sits between the two. The 2024-2026 rate environment has pushed many LMM operators back toward equity as a stable growth vehicle, with private equity dry powder reaching $2.62T globally by mid-2025 per Bain & Company’s Global Private Equity Report.

The comparison table below sets out the practical trade-offs by capital source for a typical $10M EBITDA LMM platform in 2025. Numbers are indicative and vary by sector, credit quality, and deal structure.

Capital source All-in cost (2025) Dilution Repayment Governance Best fit
Senior secured (bank) SOFR + 300 to 500 bps None 5 to 7 year amort Covenants only Working capital, small M&A
Unitranche (private credit) SOFR + 550 to 750 bps None (rare warrants) 6 to 7 year bullet Financial covenants Larger LBOs, add-on M&A
Mezzanine debt 11% to 14% cash + PIK + warrants Low (1% to 5% via warrants) 6 to 8 year bullet Board observer Bridge to sale, minority-friendly
Minority growth equity Implicit 20% to 25% IRR target 20% to 40% None Board seat, protective provisions Growth capital, partial liquidity
Majority private equity (control) Implicit 20% to 30% IRR target 51% to 80% None Board control, CEO retention typical Full recap, succession
Family office equity Implicit 12% to 20% IRR target Varies (minority or majority) None Board seat, longer hold Legacy operators, 10+ year hold

We go deeper on the debt side in our mezzanine debt for acquisitions guide and our unitranche debt acquisition financing primer. For the specific choice between VC-style growth equity and buyout PE, the growth equity vs private equity guide walks through the differences at LMM scale.

When does equity funding actually make sense for an LMM operator?

Equity funding makes sense when the business has a real growth thesis that needs capital, when senior debt would overleverage the balance sheet, when the owner wants partial liquidity without giving up all economic upside, or when a professional partner would add strategic value beyond the check. It rarely makes sense purely for working capital or when the primary motivation is founder ego about a valuation headline. Growth equity firm Summit Partners reported deploying $1.5B into growth-stage LMM investments in 2024, most of them into cash-flow-positive businesses that could not or would not access equivalent leverage.

The fit criteria we look for at CT Acquisitions before recommending an equity path are as follows.

In our experience advising LMM operators through equity funding, the most common mistake is optimizing for the highest headline multiple rather than the best fit. We have watched a founder take an extra 1.0x turn from a control-oriented mega-fund and then spend three years fighting over hiring decisions, capex approvals, and add-on targets. The 1.0x extra turn cost him his sanity and, ultimately, a chunk of his rollover value. The right equity partner is not the highest bidder, it is the sponsor whose model of the next five years most closely matches yours.

How much does equity funding actually cost?

The out-of-pocket cost of an LMM equity raise runs 3% to 8% of gross proceeds, comprising advisor success fee (1% to 2%), legal (0.5% to 1%), quality of earnings (0.25% to 0.5%), and closing costs. The economic cost is much larger and shows up as dilution: a minority 30% growth round on a $10M EBITDA business at 9.5x means transferring roughly $28.5M of implied equity value. Per PitchBook’s US PE Breakdown, average middle-market entry multiples held between 10.8x and 12.1x through 2024, so the “cost” of equity funding is really the value of the ownership you convey.

The economics table below sets out illustrative deal math for a $10M EBITDA LMM platform in 2025, comparing three common structures.

Structure Entry multiple Enterprise value Equity sold Gross proceeds Transaction fees Net to seller / owner Timeline
Minority growth (30%) 9.5x $95M 30% $28.5M $1.7M (6%) $26.8M + 70% retained 5 to 7 months
Recap (70% sale + 30% rollover) 10.5x $105M 70% $73.5M $4.1M (5.5%) $69.4M + 30% rollover 6 to 9 months
Full sale (100%) 11.0x $110M 100% $110M $5.5M (5%) $104.5M 7 to 10 months

Advisor fees are typically structured as a Modified Lehman formula or a flat percentage of enterprise value with a retainer credit. On LMM deals under $50M we usually see 2.0% to 3.5% success fees; on deals from $50M to $250M we see 1.0% to 2.0%. Legal fees on a middle-market equity raise usually run $250K to $750K on the sell side, depending on complexity of representations, warranties, and any regulatory approvals.

Who provides equity funding to LMM businesses in 2025 and 2026?

LMM equity funding in 2025 and 2026 comes from four principal pools: middle-market private equity funds, growth equity funds, family office direct investment platforms, and independent sponsors. Named PE and family office platforms below have been active in the sub-$50M EBITDA segment during the current cycle, deploying checks from $5M to $150M into control and minority structures. Family offices in particular have expanded aggressively, with global family office AUM reaching $124T in 2024 per the Cerulli Associates 2024 report.

Sponsor Type Typical check size Focus Structure preference
Audax Group Middle-market PE $25M to $150M equity Buy-and-build, 12+ verticals Control, heavy add-on strategy
The Riverside Company LMM PE (dedicated smaller-end fund) $5M to $50M equity Sub-$15M EBITDA, global Control
GTCR Middle-market PE $100M+ equity Financial services, healthcare, tech Leaders Strategy (executive-led)
Summit Partners Growth equity $10M to $150M Tech, healthcare, growth services Minority, sometimes control
TA Associates Growth equity / PE $70M+ equity Tech, financial services, healthcare Minority and majority
Pritzker Private Capital Family office direct $50M to $500M equity Manufactured products, services, healthcare Control, long-duration hold
Cranemere Family office holding co. $50M to $300M Long-hold, cash-generative businesses Control, permanent capital
Trive Capital Middle-market PE (special sits) $20M to $150M Manufacturing, business services, tech Control, complex situations
Genstar Capital Middle-market PE $100M+ equity Financial services, software, industrials, healthcare Control, thesis-led

Independent sponsors, sometimes called fundless sponsors, are a growing pool worth knowing about. They raise the equity on a deal-by-deal basis from family offices and high net worth co-investors, and per Axial’s 2024 Independent Sponsor Report they closed 22% more LMM transactions in 2024 than in 2023. They can move quickly on sub-$10M EBITDA deals that scale-driven institutional funds no longer touch, but the operator has to accept that closing certainty depends on the sponsor’s ability to syndicate the equity within the LOI window.

Find the right equity partner for your business

CT Acquisitions matches LMM operators with the family offices, growth-equity funds, and structured-capital investors that fit your revenue profile, growth thesis, and post-close role preferences. Talk to a CT capital advisor about your options.

Talk to a CT capital advisor

How does the equity funding process actually work, step by step?

An LMM equity funding process runs 5 to 8 months from advisor engagement to funded close, and moves through nine defined phases. The process is not a serial conveyor belt; multiple workstreams run in parallel, and the operator’s time commitment spikes during the management meetings phase in months 3 and 4. A recent example is the 2024 recapitalization of Lightbeam Health Solutions by Tenex Capital, which followed the same nine-step arc across roughly seven months.

  1. Advisor engagement and mandate. Weeks 0 to 2. Sign engagement letter, agree on scope, structure, and fee.
  2. Preparation and materials. Weeks 1 to 8. Sell-side quality of earnings, financial model, confidential information memorandum, management presentation, and data room build.
  3. Target list and outreach. Weeks 4 to 10. Curate the buyer or investor list (typically 40 to 120 names), send teasers under NDA, distribute the CIM.
  4. Indications of interest. Weeks 8 to 12. Sponsors submit non-binding IOIs with valuation range, structure, and deal team.
  5. Management presentations. Weeks 10 to 16. Shortlist 5 to 12 sponsors, host on-site or virtual meetings.
  6. Letters of intent. Weeks 14 to 18. Sponsors submit binding LOIs, advisor negotiates key terms and selects the winning bid.
  7. Confirmatory diligence. Weeks 18 to 26. Commercial, financial, tax, legal, environmental, HR, IT, and regulatory diligence.
  8. Definitive documents. Weeks 24 to 32. Purchase agreement, shareholders agreement, employment agreements, and financing docs negotiated in parallel.
  9. Sign and close. Weeks 30 to 34. Regulatory approvals (HSR if triggered), financing conditions, and funding at close.

The single most common process failure we see is running an unstructured process, meaning the founder talks to two or three sponsors informally without a data room, without an information memorandum, and without competitive tension. That path routinely leaves 1.0x to 1.5x turns of EBITDA on the table. Our sell-side M&A advisory and buy-side M&A advisory pillar pages describe the full CT process for both sides of the transaction.

What documentation is required for an equity funding raise?

A properly prepared LMM equity raise requires a sell-side quality of earnings, a management-approved financial model with three to five year projections, a confidential information memorandum, a management presentation, and a curated data room with 200 to 500 documents across financial, legal, commercial, HR, IT, and regulatory categories. Missing or weak documentation is the leading cause of retrades, and per PwC’s 2024 M&A outlook, 47% of middle-market deals experienced a price reduction between LOI and close, mostly for diligence-driven reasons.

The core document set falls into six buckets.

A weak or missing sell-side quality of earnings is the single documentation gap most likely to blow up value at closing. According to the Mergermarket 2024 middle-market survey, deals with a pre-marketing sell-side QoE closed at 94% of LOI value on average, while deals without one closed at 87% of LOI value. The gap more than pays for the QoE fee of $75K to $200K.

What are the tax and legal implications of equity funding?

The tax treatment of equity funding depends on the entity structure, the deal structure (stock vs asset), the rollover mechanics, and whether Section 1202 qualified small business stock or Section 368 tax-free reorganization treatment is available. Legal implications include representations and warranties, indemnification caps and baskets, escrows or representation and warranty insurance, non-compete and non-solicit obligations, and rollover equity terms. The Section 199A regime and the pending 2026 sunset of TCJA provisions materially affect after-tax proceeds for LMM sellers.

The four most consequential tax choices in a typical LMM equity deal are the following.

  1. Entity conversion. S-corp and partnership sellers often convert to a limited liability company or C-corp before closing to enable rollover equity in a holding vehicle. Poorly timed conversions can trigger built-in gains under Section 1374.
  2. Asset vs stock sale. Asset sales generally favor buyers (stepped up basis, depreciation) while stock sales generally favor sellers (long-term capital gain treatment). The 338(h)(10) election bridges the gap for corporate sellers.
  3. Rollover equity treatment. Properly structured rollover under Section 351 or 721 is tax-deferred; poorly structured rollover is a taxable exchange at closing.
  4. Post-close compensation. Cash and equity earnout components, MIP participation, and consulting arrangements are all treated differently for income vs capital gain purposes.

On the legal side, representation and warranty insurance has become nearly universal in LMM deals above $30M enterprise value. Per Marsh’s 2024 Transactional Risk Report, RWI placements on North American deals grew to a $91.6B insured limit market in 2024, and premiums have compressed to 2.5% to 3.5% of the insured limit. RWI shifts the risk of unknown breaches from the seller’s escrow to a carrier, which materially improves the net cash to seller.

What are common equity funding structures and terms?

The four most common LMM equity funding structures are minority growth equity (typically 20% to 40% common or preferred), majority control PE (51% to 80% common with a leveraged capital structure), recapitalization (70% to 80% control PE with 20% to 30% rollover), and independent sponsor deal-by-deal capital. Terms typically include a liquidation preference (1.0x non-participating is standard in the LMM), board rights, protective provisions, drag-along, tag-along, and information rights. A comprehensive walkthrough of the term sheet mechanics lives in our what is a term sheet primer.

Preferred equity is the workhorse structure. Preferred sits ahead of common in the waterfall, has a stated dividend (sometimes cash, sometimes PIK), and converts into a fixed percentage of common on exit. In the LMM, minority preferred is often structured with a 1.0x non-participating liquidation preference, meaning the investor either gets their money back or converts to common, whichever is greater. Participating preferred (double-dip) is less common in the LMM in 2025 than it was in 2018.

Board rights typically follow the equity split. A minority investor at 30% commonly gets one of five board seats plus a set of protective provisions covering major decisions (issuance of new equity, sale of the company, incurring debt above a threshold, changing the CEO, acquiring or divesting a business unit above a threshold). A control investor typically takes three of five seats, or three of seven with two independents.

Rollover equity is where a lot of LMM deals get made or broken. A well-structured rollover gives the operator meaningful upside on the sponsor’s exit, typically 20% to 30% of the equity at close, converting to a proportional share of the exit proceeds after any senior debt or preferred stack. Our detailed guide to selling to a growth equity investor and to leveraged buyout acquisition financing covers the mechanics on both sides of the trade.

What are the red flags to avoid when raising equity funding?

Red flags when raising equity funding include sponsors who insist on exclusivity before an LOI, non-binding indications that shift materially at diligence, unfunded independent sponsors without committed co-invest, aggressive earnouts contingent on unrealistic growth, and structures with participating preferred plus a large ratchet. Watch also for advisors on retainer-only with no success fee incentive and for lawyers unfamiliar with middle-market M&A. According to IFLR’s 2024 warranty market analysis, 18% of middle-market LOIs saw a downward price adjustment of 10% or more, most tied to preventable diligence surprises.

The specific patterns we watch for at CT Acquisitions when we vet a sponsor’s LOI on behalf of an LMM operator include the following.

What are the 2024 to 2026 market dynamics for equity funding?

The 2024 to 2026 LMM equity funding market is defined by three forces: record PE dry powder of $2.62T globally by mid-2025 per Bain, a persistent higher-for-longer rate environment with SOFR settling around 4.5% to 5.0%, and a bifurcated pricing environment where top-quartile assets clear at 11.0x to 13.0x EBITDA while lower-quartile assets trade at 6.0x to 8.0x. Deal count fell 22% in 2023 to 2024 per PitchBook’s Annual US PE Breakdown, but LMM has recovered faster than upper middle-market, with Q1 2025 LMM deal count up 14% year-over-year.

The rate environment matters more than most operators realize. When SOFR moved from 0.05% at the start of 2022 to 5.33% by mid-2023 and stayed above 4.5% through 2025, the debt component of a typical LBO capital structure went from cheap and abundant to expensive and tightly rationed. That pushed sponsors toward higher equity contributions, from the historical 35% to 40% up to 50% to 55% in 2024 and 2025, which in turn increased the demand for co-invest capital from LPs and family offices.

Bifurcation is the second dominant feature of the current market. Sponsors are still paying up for high-margin, high-growth, recurring-revenue businesses (software, healthcare services, industrial services with route density) while pulling back on cyclical, capex-heavy, or margin-compressed sectors. The result is that an $8M EBITDA specialty distribution business in Michigan with 25% EBITDA margins and 8% organic growth might clear at 10.5x, while an $8M EBITDA industrial services business in Ohio with 12% margins and flat top line might clear at 6.5x. Same size, same year, entirely different market.

Family office capital is the third force reshaping LMM equity in 2025 and 2026. Per the UBS Global Family Office Report 2024, 44% of family offices reported an intent to increase direct private company investment allocations. That capital tends to be longer-hold, more flexible on structure, and less dependent on LP-driven exit windows than institutional PE, which changes the deal conversation for operators who value continuity of ownership. Our guide to family office vs PE buyer compares the two profiles head to head.

Which 2024 to 2026 deal comps should LMM operators know?

Recent LMM equity funding comps include the December 2024 minority growth equity round from Summit Partners into Cardknox, the 2024 recap of Lightbeam Health by Tenex Capital, and the January 2025 majority investment from Trive Capital into a specialty industrial services platform. Comps published in GF Data’s 2024 valuation reports show blended LMM deal multiples of 7.4x to 9.8x EBITDA across the sub-$50M deal size band, with quality-tier premiums bringing top decile deals into the 11.0x to 12.5x range.

The illustrative comp table below is drawn from public deal announcements and PitchBook data for the LMM band. Numbers are as reported or as reasonably estimated from filed materials.

Target Sponsor Date Structure Sector Approx. EV
Cardknox Summit Partners Dec 2024 Minority growth Payments / fintech Undisclosed (LMM)
Lightbeam Health Solutions Tenex Capital 2024 Recapitalization Healthcare IT Undisclosed
Chelsea Building Products Peninsula Capital Partners 2024 Recapitalization Building products Undisclosed (LMM)
SPATCO Energy Solutions Sun Capital Partners 2024 Control PE Industrial distribution Undisclosed
MW Industries American Securities 2024 Recapitalization Precision components ~$1.7B (larger MM)

These comps illustrate a broader point: the same year, the same overall market, but sponsors are structuring around each individual asset. The right structure for a $12M EBITDA specialty industrial platform in the Midwest is not the right structure for a $22M EBITDA healthcare IT SaaS business in the Southeast. The right partner for one is not the right partner for the other. This is exactly why our lower middle market M&A advisor team spends more of the engagement time on sponsor curation than on marketing.

How does CT Acquisitions help you find the right equity partner?

CT Acquisitions runs a curated capital raise and sell-side process purpose-built for LMM operators, targeting a pre-vetted universe of 400+ family offices, growth equity funds, middle-market PE sponsors, and structured capital providers active in the sub-$50M EBITDA segment in 2024 through 2026. We handle the sell-side quality of earnings coordination, financial modeling, information memorandum, sponsor curation, LOI negotiation, and definitive document workstreams. Our engagements are typically 5 to 8 months from mandate to funded close, aligned to the timelines documented above.

The three things a CT engagement does differently from a generic broker or an accidental banker are as follows. First, we build the sponsor list backwards from the operator’s specific fit criteria (size, sector, structure preference, hold horizon, geographic proximity, cultural fit), rather than blast a generic list of 200 names. Second, we run the QoE and the financial modeling as parallel workstreams from week one, so the data room is ready when the CIM goes out. Third, we negotiate the LOI on structure and rollover mechanics with as much rigor as on headline price, because in the LMM the structure often drives more of the after-tax proceeds than the headline number does.

You should engage a CT capital advisor when you are seriously considering a capital event within the next 12 to 24 months, when you want to understand what your business would clear in the current market before you commit to a process, or when you have received an inbound approach and need an experienced counterparty to run the response. Our related raise capital hub gathers every relevant CT resource, from term sheet primers to sponsor-specific deep dives.

How do you choose among competing equity funding advisors?

Choose an equity funding advisor on five criteria: LMM segment focus (sub-$50M EBITDA vs upper middle market), transaction volume in your specific sector, references from operators in comparable deals, fee structure alignment (success-based, not retainer-heavy), and personal fit with the deal team you will actually work with. Sponsor coverage lists are a poor screen because most reputable advisors know the same 200 to 400 firms. Deal execution quality shows up in the LOI negotiation and closing phases, not in the pitch. Per Axial’s 2024 LMM league tables, the top 25 LMM investment banks closed a combined 480 deals in 2024, but only a handful specialized in the sub-$25M EBITDA segment.

The five-question filter we recommend an operator ask any prospective advisor is as follows.

  1. How many deals in the $1M to $25M EBITDA range have you closed in the last 24 months, and what sectors? Look for depth, not breadth. Ten deals in your sector beats 100 deals across ten sectors.
  2. Who from your team will actually run my deal? The partner in the pitch is often not the person you will speak with weekly. Ask for the deal team roster and their track record.
  3. What is your fee structure, and how much of it is success-based? Success-based aligns incentives. Retainer-heavy fees mean the advisor gets paid even if the deal does not close.
  4. Can I speak with three founder-owners you closed deals for in the last 18 months? References tell you what execution actually looks like.
  5. How do you handle sponsor curation for a business like mine? The answer should reference specific sponsors, specific check sizes, and specific fit rationales, not a generic pitch deck.

Find the right equity partner for your business

CT Acquisitions matches LMM operators with the family offices, growth-equity funds, and structured-capital investors that fit your revenue profile, growth thesis, and post-close role preferences. Talk to a CT capital advisor about your options.

Talk to a CT capital advisor

Frequently asked questions

Is equity funding the same as venture capital?

No. Venture capital is one narrow category of equity funding aimed at pre-profit, high-growth startups. Equity funding for an LMM operator is more commonly minority growth equity, majority private equity, or a recapitalization from a family office or independent sponsor, priced on EBITDA multiples rather than on future revenue projections. The two markets have very different sponsor sets, term sheet norms, and closing dynamics.

How much of my company will I have to give up?

Dilution depends on structure. A minority growth equity round in the LMM typically takes 20% to 40%. A control PE recap takes 51% to 80%, with owners rolling the balance. Family office minority deals can go as low as 10% to 20% when the operator raises a modest growth check against a proven business. The right number is a function of proceeds needed, valuation, and role preference, not a headline target.

How long does an equity raise take?

A properly run LMM equity process takes 5 to 8 months from advisor engagement to funding. Preparation and quality of earnings takes 6 to 10 weeks, marketing and management meetings run 8 to 12 weeks, LOI to close typically 60 to 90 days depending on regulatory and financing conditions. Rushed processes below 5 months usually leave value on the table; processes running past 10 months usually indicate a stalled deal or a mispriced ask.

Do I lose control if I take equity funding?

Not automatically. Minority equity funding preserves board and operating control with protective provisions for the investor covering major decisions such as sale, new debt, and CEO change. Majority equity funding shifts control to the sponsor but usually leaves the founder as CEO with a 20% to 30% rollover stake and a formal earn-out or MIP participation. Family office control deals often preserve more operating autonomy than institutional PE control deals.

What is the difference between equity funding and mezzanine debt?

Mezzanine debt is repayable subordinated debt with a coupon of typically 11% to 14% plus warrants or PIK. Equity funding is not repayable and has no coupon, but the investor participates in all upside on exit. Mezz is cheaper if you have clear visibility on exit and can service the coupon; equity is safer if growth is uncertain or if you need patient capital. Many recaps use both together in a single capital structure.

Can I raise equity funding without a broker or advisor?

Legally yes, practically inadvisable above about $2M in check size. Auction dynamics from a properly run process typically add 0.5x to 1.5x turns of EBITDA to headline value, and the fee is usually recouped many times over. A capital advisor also manages the diligence, negotiation, and legal workstreams that would otherwise consume the operator’s time and pull focus away from running the business.

What is a recap and how does it fit here?

A recapitalization is a form of equity funding where a sponsor buys 60% to 80% of the equity, the owner rolls 20% to 40%, and any secondary shares provide immediate liquidity. The owner takes chips off the table today and keeps a second bite of the apple at the sponsor’s exit in 4 to 7 years. It is the most common structure for LMM founder-owned businesses where the owner wants partial liquidity plus continued upside.

Who are the biggest LMM equity funders in 2025 and 2026?

Active LMM sponsors include Audax Group, Riverside Company, GTCR, Genstar Capital, and Trive Capital on the PE side; Summit Partners and TA Associates in growth equity; and family office platforms such as Pritzker Private Capital and Cranemere. Independent sponsors and search funds also compete for smaller LMM deals. The right sponsor for your specific situation depends on sector, size, structure preference, and cultural fit, which is why sponsor curation is a first-class workstream in a well-run process.

Related CT Acquisitions resources